AzTrials
AzTrials

Substance Use RiskNCT06221839

Structural Stressors, Reward Related Decision Making and Substance Use Risk

An observational study of Substance Use Risk and Structural Stressors, run by Columbia University at 2 sites in 2 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study, which has a pilot phase (R61) and a second, larger phase (R33), is to learn about the impact of indicators of structural stressors (SS) on substance use risk in Puerto Rican adolescents living in the mainland US and in Puerto Rico. Read more about this study

Who is it for?
Ages 11 to 14 yearsHealthy volunteers can take part
Conditions the study is for
Substance Use Risk, Structural Stressors
How many people
72 participants
Where
2 sitesin 2 countries
Study dates
3 Feb 2026to Aug 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 14 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Puerto Rican adolescents living in the mainland US and in Puerto Rico, and a parent or caregiver of each adolescent.

Who may be able to join

  • The adolescent participant is a biological or non-biological child of a member of the original Boricua Youth Study (BYS) sample.
  • The adolescent is between the ages of 11 to 14.5 at the time of recruitment, and 11 to <15 at the time of study participation.
  • If the parent/caregiver is not an original BYS member, they have provided a consent to contact form.
  • Parent/caregiver is between the ages of 18-64.5 at the time of recruitment and 18 to <65 at the time of study participation

Who cannot join

  • Major neurological disorder (e.g. seizure disorder) or cognitive impairment (e.g., moderate to severe Autism Spectrum Disorder, Intellectual Disability)
  • Exclusion criteria for the MRI scan only: MRI contraindications (e.g., irremovable metal on the body, pacemaker, braces, etc.; pregnancy (while required by NYSPI).

Trial locations and contacts

2 sites in 2 countries. Contact the study team or a site near you to ask about taking part.

Tamara J. Sussman, PhD contact

646-774-6048

Tamara.Sussman@nyspi.columbia.edu

2 sites in 2 countries

United States1 site, 1 recruiting
  • Columbia University Irving Medical Center

    New York, New York, 10032

    Recruiting

Other trials in United States

Puerto Rico1 site, 1 recruiting
  • University of Puerto Rico, Medical Sciences Campus

    San Juan, Puerto Rico, 00921

    Recruiting

Other trials in Puerto Rico

About this study

Official title: Structural Stressors, Neurocognition in Reward Related Decision Making and Substance Use Risk

The goal of this observational study, which has a pilot phase (R61) and a second, larger phase (R33), is to learn about the impact of indicators of structural stressors (SS) on substance use risk in Puerto Rican adolescents living in the mainland US and in Puerto Rico. To do this, we will look at how indicators of SS relate to brain structure, brain function during reward-related choices, belief in a just world, and substance use risk indicators in Puerto Rican adolescents living in the mainland US (mostly in New York) and in Puerto Rico (mostly in San Juan). We are currently focused on the R61 (pilot) phase. This pilot phase aims to answer the question: Is there a relationship between indicators of SS and brain structure, brain function during reward-related decision making, and belief in a just world? If we are able to establish a relationship between SS indicators and outcomes, we will continue to the second phase of the study at that time.

We will be collecting data from a total of 72 adolescents and their parents; n=36 in NY; n=36 in PR). Participation in the research study will include: 1. an interview with the parent or caregiver (approximately 2.5 hours) regarding the child's demographics, mental health symptoms, past experiences, the parent or caregiver's relationship with the child, as well as cultural values and acculturation; 2. an interview with the child (approximately 2.5 hours) regarding the child's past experiences, their current beliefs, personality traits and mental health symptoms; 3. an MRI scan for the child including task-based, structural and resting-state functional connectivity (approximately 1 hour).

Read the detailed description

Substance use disorders (SUDs) are common, and are associated with significant impairment and public health costs (Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health 2015). Adolescence is a key developmental period involving significant neurodevelopmental changes and is a critical risk period for the initiation of substance use and related negative outcomes, including substance use problems in adulthood (Andrews, Ahmed, \& Blakemore, 2021; Blakemore, 2012; Dawson, Goldstein, Chou, Ruan, \& Grant, 2008; Gray \& Squeglia, 2018; Guttmannova et al., 2011; Irons, Iacono, \& McGue, 2015; McCabe et al, 2022). Improved understanding of the neurocognitive mechanisms of substance use risk could lead to novel approaches to prevention.

The effects of structural structures (SS) are harmful. Between 50-75% of minoritized populations in the US report discriminatory treatment (Lee, Perez, Boykin, \& Mendoza-Denton, 2019), and experiences of ethnoracial discrimination during childhood and adolescence are associated with increased substance use in youth (e.g. Benner, Wang, Shen, Boyle, Polk, \& Cheng, 2018). While the impact of interpersonal discrimination on substance use risk in youth is important, it focuses on perceptions of experiences rather than the ways that minoritized individuals are systematically disadvantaged. Thus, we plan to measure the impact of indicators of structural racism on substance use risk, while controlling for experiences of discrimination, to determine the impact of SS indicators over and above individual experiences. Structural factors impact SUD risk: The impact of SS indicators on adolescent substance use risk is currently unknown, however, ethnoracial inequities have been documented in structural indices associated with increased substance use risk, including ethnoracial inequities in 1) household income in the US (Rivenbark et al, 2019), 2) high school dropout rates (Maynard, Salas-Wright, \& Vaughn, 2015; Townsend, Flisher, \& King, 2007), and 3) neighborhood violence (Fagan, Wright, \& Pinchevsky, 2014; Lambert, Brown, Phillips, \& Ialongo, 2004). Thus, generating a composite of indicators of SS using racial differences in census tract level income and educational attainment, and precinct level murder rates will provide an SS measure relevant for adolescent substance use risk.

Structural factors impact brain development. Neighborhood-level structural factors have been shown to impact brain structure and function (Maxwell, Taylor, \& Barch, 2022; Taylor, Cooper, Jackson, \& Barch, 2020), suggesting it is plausible that SS is related to neurodevelopmental changes. Neuroscience informs structural change. Results from neuroscience have influenced policy, e.g. child tax credits (e.g. Vickers, Zamani-Hank, \& Margerison, 2022) and court decisions, e.g. juvenile sentencing practices (e.g. Miller v. Alabama SC. 2012). Thus, neuroscience plays an important role in motivating and shaping structural-level changes, particularly for children and adolescents, underlining the importance of examining neural correlates of SS indicators.

Individual Differences in Reward-Related Decision Making Can Contribute to Substance Use Risk. Mechanisms by which greater exposure to SS could increase substance use are not known. Individuals with SUDs tend to have to prefer smaller, sooner over larger, later rewards - i.e. steeper delay discounting, compared to individuals without SUDs or related problems (e.g. Amlung, Vedelago, Acker, Balodis, \& MacKillop, 2017.). Steeper delay discounting has been interpreted as a sign of maladaptive impulsivity (Amlung, Vedelago, Acker, Balodis, \& MacKillop, 2017). However, learning to wait for larger, later rewards is theorized to emerge developmentally alongside a belief in a just world, as it is only sensible to wait for larger rewards if people get what they deserve (Lerner \& Miller, 1978). Belief in a just world relates to reward related decision making; both 1) exposure to unjust scenarios and 2) reduced belief in a just world is associated with steeper delay discounting (Lerner \& Miller, 1978). Thus, growing up in an unjust environment with high levels of SS, may promote steeper delay discounting. Steeper delay discounting may help secure available rewards in unjust environments. However, given the well-established link between steeper delay discounting and SUDs (Amlung, Vedelago, Acker, Balodis, \& MacKillop, 2017), when the reward is a substance, and immediate use is chosen over long-term health outcomes, this adaptation to the environment could increase the odds of risky substance use (Kim-Spoon et al, 2019). Improved understanding of how SS leads to increased substance use risk could inform novel prevention/intervention efforts at the structural level. For example, if steeper delay discounting moderates the relationship between higher levels of SS indicators and increased substance use risk, interventions could target 1) structural inequality, particularly the indicators measured, and 2) reward related decision making (Stein et al, 2016) to reduce the harmful effects of SS (Stein et al, 2016).

Protective Factors: Structural \& Family-Level Protective Factors. Area level protective factors may buffer the negative effects of SS on substance use risk, including the availability of churches and the percentage of minority owned businesses. The number of neighborhood churches per capita have been associated with lower likelihood of SUDs (Stockdale et al, 2007). Similarly, the number of minority-owned businesses in a neighborhood has a positive effects. For example, an increased number of Latine-owned businesses relates to reduced property crime rates (Stansfield, 2014). Thus, we will examine if the number of local, churches and Latine-owned businesses in the area buffers the effect of SS indicators on neural structure and function. Family-level processes, such as higher parental monitoring, parent-child communication and familism are associated with reduced substance use risk in Latine youth (Pokhrel, Unger, Wagner, Ritt-Olson, \& Sussman, 2008; German, Gonzales, \& Dumka, 2009). Examining the buffering effect of familial-level factors on the relationship between SS and neurodevelopment will inform if targeting family processes can help protect against the negative impact of SS.

The Boricua Youth Study, an opportunity: The Boricua Youth Study (BYS) started in 2000 with the goal of learning more about the mental health of Puerto Rican youth living in two contexts: San Juan, Puerto Rico, and the South Bronx, New York. Longitudinal data were collected over 3 Waves, between 2001-2004. The original youth participants of the BYS now have children, allowing a second generation of BYS to participate in research. Thus, working with BYS is an opportunity to: 1) measure SS indicators in two distinct contexts and 2) isolate the impact of SS indicators on substance use, by controlling for familial factors. This study will generate separate measures of SS indicators, with particular relevance to substance use risk-related outcomes, for Puerto Rican youth living in two contexts: in the US mainland and in PR. Thus, we will be able to 1) compare the structure of SS indicators between the two contexts; 2) determine if certain SS indices contribute more to substance use risk in one site than another. Intergenerational transference of substance use is well established. Furthermore, it is possible that familial history of SUD could influence youths' delay discounting choices, as has been found empirically (Dougherty et al, 2014). Therefore, to isolate the impact of SS indicators on brain structure, delay discounting related brain activity, and SUD risk, it is crucial to account for familial SUD risk factors. Other large datasets do not have prospectively captured data regarding familial SUD risk factors. Therefore, working with the BYS-ECHO will add key complementary information by enabling us to directly control for prospectively captured familial SUD risk factors, e.g. parental SUD and impulsivity.

R61 Specific Aims: Proof of Concept of relationship of indicators of SS with Neurocognitive Mechanisms: We will invite 72 children (aged 11-14, 50% female, 50% from SBx, 50% from PR), to provide home address history (last 5 yrs), substance use risk, belief in a just world and magnetic resonance imaging (MRI) for brain structure and DD-related brain function. Higher levels of SS indicators will relate to: Aim 1, Hypothesis 1 (H1): adolescent brain structure: lower grey matter volume of superior frontal, dorsal lateral and medial prefrontal cortices; Aim 2, H2: Steeper DD and less DD-related activity in dorsal medial prefrontal and anterior cingulate cortices, ventral striatum and insula; Aim 3, H3: Reduced belief in a just world. A moderate effect size association (r > 0.30) found for H1, H2, or H3 will justify progression to the R33 phase.

Keywords
Adolescent Behavior, Reward Related Decision Making, fMRI
Medical subject headings
Adolescent Behavior

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adolescent Brain Structure

    Grey matter volume of superior frontal, dorsal lateral and medial prefrontal cortices

    Measured: Up to 3.5 hours

  2. Steeper Delay Discounting

    The delay discounting k factor, a measure of how much perceived value is affected by delay in reward delivery

    Measured: Up to 3.5 hours

  3. Delay Discounting Related Brain Function

    The brain will be more active for immediate vs delayed rewards in the dorsal medial prefrontal cortex, and the ventral striatum, and more active for delayed vs immediate rewards in the insula, while the anterior cingulate will track the value of the reward.

    Measured: Up to 3.5 hours

  4. Belief in a Just World

    Score on the Belief in a Just World Scale (Dalbert, 1999)

    Measured: Up to 3.5 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2024
  2. Study start3 Feb 2026
  3. Primary completionAug 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06221839
Sponsor's protocol ID
AAAV4120
Other IDs
1R61DA058985, 8499
Status last verified
Nov 2026
First submitted
13 Dec 2023
Last updated
6 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Amlung M, Vedelago L, Acker J, Balodis I, MacKillop J. Steep delay discounting and addictive behavior: a meta-analysis of continuous associations. Addiction. 2017 Jan;112(1):51-62. doi: 10.1111/add.13535. Epub 2016 Sep 1.

    PubMed 27450931
  • Andrews JL, Ahmed SP, Blakemore SJ. Navigating the Social Environment in Adolescence: The Role of Social Brain Development. Biol Psychiatry. 2021 Jan 15;89(2):109-118. doi: 10.1016/j.biopsych.2020.09.012. Epub 2020 Sep 17.

    PubMed 33190844
  • Benner AD, Wang Y, Shen Y, Boyle AE, Polk R, Cheng YP. Racial/ethnic discrimination and well-being during adolescence: A meta-analytic review. Am Psychol. 2018 Oct;73(7):855-883. doi: 10.1037/amp0000204. Epub 2018 Jul 19.

    PubMed 30024216
  • Dawson DA, Goldstein RB, Chou SP, Ruan WJ, Grant BF. Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders. Alcohol Clin Exp Res. 2008 Dec;32(12):2149-60. doi: 10.1111/j.1530-0277.2008.00806.x. Epub 2008 Sep 30.

    PubMed 18828796
  • Dougherty DM, Charles NE, Mathias CW, Ryan SR, Olvera RL, Liang Y, Acheson A. Delay discounting differentiates pre-adolescents at high and low risk for substance use disorders based on family history. Drug Alcohol Depend. 2014 Oct 1;143:105-11. doi: 10.1016/j.drugalcdep.2014.07.012. Epub 2014 Jul 23.

    PubMed 25096271
  • Fagan AA, Wright EM, Pinchevsky GM. The protective effects of neighborhood collective efficacy on adolescent substance use and violence following exposure to violence. J Youth Adolesc. 2014 Sep;43(9):1498-512. doi: 10.1007/s10964-013-0049-8. Epub 2013 Oct 30.

    PubMed 24170438
  • German M, Gonzales NA, Dumka L. Familism Values as a Protective Factor for Mexican-origin Adolescents Exposed to Deviant Peers. J Early Adolesc. 2009 Feb;29(1):16-42. doi: 10.1177/0272431608324475.

    PubMed 21776180
  • Guttmannova K, Bailey JA, Hill KG, Lee JO, Hawkins JD, Woods ML, Catalano RF. Sensitive periods for adolescent alcohol use initiation: predicting the lifetime occurrence and chronicity of alcohol problems in adulthood. J Stud Alcohol Drugs. 2011 Mar;72(2):221-31. doi: 10.15288/jsad.2011.72.221.

    PubMed 21388595
  • Irons DE, Iacono WG, McGue M. Tests of the effects of adolescent early alcohol exposures on adult outcomes. Addiction. 2015 Feb;110(2):269-78. doi: 10.1111/add.12747. Epub 2014 Oct 27.

    PubMed 25251778
  • Kim-Spoon J, Lauharatanahirun N, Peviani K, Brieant A, Deater-Deckard K, Bickel WK, King-Casas B. Longitudinal pathways linking family risk, neural risk processing, delay discounting, and adolescent substance use. J Child Psychol Psychiatry. 2019 Jun;60(6):655-664. doi: 10.1111/jcpp.13015. Epub 2019 Feb 27.

    PubMed 30809804
  • Lambert SF, Brown TL, Phillips CM, Ialongo NS. The relationship between perceptions of neighborhood characteristics and substance use among urban African American adolescents. Am J Community Psychol. 2004 Dec;34(3-4):205-18. doi: 10.1007/s10464-004-7415-3.

    PubMed 15663207
  • Lee RT, Perez AD, Boykin CM, Mendoza-Denton R. On the prevalence of racial discrimination in the United States. PLoS One. 2019 Jan 10;14(1):e0210698. doi: 10.1371/journal.pone.0210698. eCollection 2019.

    PubMed 30629706
  • Lerner MJ, & Miller, DT. Just world research and the attribution process: Looking back and ahead. Psychological bulletin, 1978; 85(5).

  • Maxwell MY, Taylor RL, Barch DM. Relationship Between Neighborhood Poverty and Externalizing Symptoms in Children: Mediation and Moderation by Environmental Factors and Brain Structure. Child Psychiatry Hum Dev. 2023 Dec;54(6):1710-1722. doi: 10.1007/s10578-022-01369-w. Epub 2022 May 21.

    PubMed 35596841
  • Maynard BR, Salas-Wright CP, Vaughn MG. High school dropouts in emerging adulthood: substance use, mental health problems, and crime. Community Ment Health J. 2015 Apr;51(3):289-99. doi: 10.1007/s10597-014-9760-5. Epub 2014 Jul 17.

    PubMed 25030805

Questions about this trial

What is this clinical trial studying?

An observational study of Substance Use Risk and Structural Stressors, run by Columbia University at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States, Puerto Rico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tamara J. Sussman, PhD (646-774-6048, Tamara.Sussman@nyspi.columbia.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adolescent Brain Structure (time frame: Up to 3.5 hours). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06221839, which also lists 27 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in